Sources | Names Used |
---|---|
CTRPv2 | navitoclax:pluripotin (1:1 mol/mol) |
PharmacoGx | navitoclax:pluripotin (1:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | TXNDC5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | ZNF71 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CIC | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
mRNA | CSRNP3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | TRPV5 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
mRNA | BLOC1S5-TXNDC5 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
mRNA | TSSK3 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | HTR2A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
mRNA | CBLN4 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
mRNA | PEX19 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |